Related references
Note: Only part of the references are listed.Mitochondrial control of inflammation
Saverio Marchi et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Immunogenic cell stress and death
Guido Kroemer et al.
NATURE IMMUNOLOGY (2022)
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella et al.
NATURE IMMUNOLOGY (2022)
Immuno-epigenetic escape of cancer stem cells
Lorenzo Galluzzi et al.
NATURE IMMUNOLOGY (2022)
Immunomodulation by targeted anticancer agents
Giulia Petroni et al.
CANCER CELL (2021)
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
Julian Swatler et al.
CANCERS (2021)
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
John M. Magenau et al.
BLOOD ADVANCES (2021)
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia
Hao Jiang et al.
LEUKEMIA & LYMPHOMA (2021)
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
Takahiro Yamazaki et al.
ONCOIMMUNOLOGY (2021)
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies
Oliver Kepp et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Maria Esperanza Rodriguez-Ruiz et al.
NATURE IMMUNOLOGY (2020)
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
Takahiro Yamazaki et al.
NATURE IMMUNOLOGY (2020)
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Opposing Roles of Type I Interferons in Cancer Immunity
Giselle M. Boukhaled et al.
Annual Review of Pathology-Mechanisms of Disease (2020)
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin et al.
NATURE REVIEWS CANCER (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
Type I interferon signaling, regulation and gene stimulation in chronic virus infection
Sabelo Lukhele et al.
SEMINARS IN IMMUNOLOGY (2019)
Interferon-Stimulated Genes: What Do They All Do?
John W. Schoggins
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma
Chen Zhu et al.
ONCOIMMUNOLOGY (2019)
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Claire Vanpouille-Box et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients
Maria Esperanza Rodriguez-Ruiz et al.
ONCOIMMUNOLOGY (2019)
Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints
Diana Saleiro et al.
SEMINARS IN IMMUNOLOGY (2019)
Cytosolic DNA Sensing in Organismal Tumor Control
Claire Vanpouille-Box et al.
CANCER CELL (2018)
A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1
Erkin Erdal et al.
GENES & DEVELOPMENT (2017)
The oncolytic peptide LTX-315 triggers immunogenic cell death
H. Zhou et al.
CELL DEATH & DISEASE (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
The interferon-alpha revival in CML
Moshe Talpaz et al.
ANNALS OF HEMATOLOGY (2015)
Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Jitka Fucikova et al.
FRONTIERS IN IMMUNOLOGY (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
Peter S. Linsley et al.
PLOS ONE (2014)
Interferons and Their Stimulated Genes in the Tumor Microenvironment
HyeonJoo Cheon et al.
SEMINARS IN ONCOLOGY (2014)
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
Tobias Bald et al.
CANCER DISCOVERY (2014)
An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival
Antoine M. Snijders et al.
ONCOTARGET (2014)
Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation
Anaig Dagorne et al.
ANNALS OF HEMATOLOGY (2013)
Interferon may be back on track to treat acute myeloid leukemia
Evelien L. J. M. Smits et al.
ONCOIMMUNOLOGY (2013)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
Jamie J. Bernard et al.
NATURE MEDICINE (2012)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
Interferon-α in acute myeloid leukemia: an old drug revisited
S. Anguille et al.
LEUKEMIA (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis
Xiaohui Bi et al.
BREAST CANCER RESEARCH (2011)
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
Tina Baessler et al.
BLOOD (2010)
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
Tina Baessler et al.
CANCER RESEARCH (2009)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model
Reuben Benjamin et al.
BLOOD (2007)
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
KJ Hope et al.
NATURE IMMUNOLOGY (2004)
Share Paper
